: :
 
   
   
 
Bafna Pharmaceuticals Ltd received Medicines and Health Care Products Regulatory Agency (MHRA) approval for its Grantlyon facility meant for exports to the UK markets. Bafna has become 35th company in the Indian pharmaceuticals industry (IPI) to receive MHRA approval.
 
BAFNA PHARMACEUTICALS was started in 1981 as a proprietary concern by Mr. Bafna Mahaveer Chand and started its own manufacturing unit in October 1984. It was converted into a Public Limited Company in 28th March 1995 and known as BAFNA PHARMACEUTICALS LIMITED.
  

BAFNA PHARMACEUTICALS started its production with tablets facility and subsequently added capsule and oral syrup facilities respectively. BAFNA has always focused on institutional & generic supply to keep its production line busy. It was also concentrating on registration of its products.....
 
 
 
  BAFNA pharmaceuticals ltd considers the quality of its products an obligation and prerequisite of its activities...
 
 
  The company has been accorded the status of an “EXPORT HOUSE” in recognition of its excellent Export Performance....
 
 
  Click here to view the infrastructure of the company.
 
: : : : : : : : : :
: